deltatrials
Completed PHASE4 NCT00512187

Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial

Sponsor: Universita di Verona

Conditions Chronic Plaque Psoriasis Obesity
Interventions low calorie diet
Updated 4 times since 2017 Last updated: Aug 6, 2007 Started: Nov 30, 2005 Completion: Aug 31, 2007

This PHASE4 trial investigates Chronic Plaque Psoriasis and Obesity and is currently completed. Universita di Verona leads this study, which shows 4 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE4

    First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Universita di Verona
Data source: Universita di Verona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Verona, Italy